Woodline Partners’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $841K | Hold |
145,704
| – | – | ﹤0.01% | 819 |
|
|
2025
Q1 | $962K | Sell |
145,704
-27,000
| -16% | -$178K | 0.01% | 767 |
|
|
2024
Q4 | $1.5M | Buy |
172,704
+29,497
| +21% | +$257K | 0.01% | 696 |
|
|
2024
Q3 | $2.8M | Hold |
143,207
| – | – | 0.02% | 443 |
|
|
2024
Q2 | $2.95M | Buy |
+143,207
| New | +$2.95M | 0.03% | 385 |
|
|
2023
Q3 | – | Sell |
-867,062
| Closed | -$9.17M | – | 680 |
|
|
2023
Q2 | $9.17M | Buy |
867,062
+377,530
| +77% | +$3.99M | 0.11% | 215 |
|
|
2023
Q1 | $5.99M | Buy |
+489,532
| New | +$5.99M | 0.08% | 263 |
|
|
2022
Q4 | – | Sell |
-267,683
| Closed | -$3.66M | – | 807 |
|
|
2022
Q3 | $3.66M | Hold |
267,683
| – | – | 0.05% | 350 |
|
|
2022
Q2 | $4.91M | Hold |
267,683
| – | – | 0.08% | 262 |
|
|
2022
Q1 | $4.3M | Hold |
267,683
| – | – | 0.07% | 260 |
|
|
2021
Q4 | $3.75M | Hold |
267,683
| – | – | 0.05% | 322 |
|
|
2021
Q3 | $5.01M | Hold |
267,683
| – | – | 0.08% | 246 |
|
|
2021
Q2 | $5.58M | Buy |
+267,683
| New | +$5.58M | 0.1% | 208 |
|